GURUFOCUS.COM » STOCK LIST » Technology » Software » Genpact Ltd (NYSE:G) » Definitions » Cash, Cash Equivalents, Marketable Securities

Genpact (Genpact) Cash, Cash Equivalents, Marketable Securities : $584 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Genpact Cash, Cash Equivalents, Marketable Securities?

Genpact's quarterly cash, cash equivalents, marketable securities increased from Jun. 2023 ($491.31 Mil) to Sep. 2023 ($541.00 Mil) and increased from Sep. 2023 ($541.00 Mil) to Dec. 2023 ($583.67 Mil).

Genpact's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($899.46 Mil) to Dec. 2022 ($646.77 Mil) and declined from Dec. 2022 ($646.77 Mil) to Dec. 2023 ($583.67 Mil).


Genpact Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Genpact's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genpact Cash, Cash Equivalents, Marketable Securities Chart

Genpact Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 467.10 680.44 899.46 646.77 583.67

Genpact Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 646.77 552.28 491.31 541.00 583.67

Genpact Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Genpact  (NYSE:G) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Genpact Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Genpact's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Genpact (Genpact) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Software » Genpact Ltd (NYSE:G) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
22 Victoria Street, Canon's Court, Hamilton, BMU, HM 12
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. The company is a General Electric spin-off, which is still a large source of revenue for Genpact.
Executives
Kathryn Vanpelt Stein officer: Senior Vice President 40 WEST 24TH STREET, APT 3N, NEW YORK NY 10010
N. V. Tyagarajan officer: Executive Vice President 825 EIGHTH AVENUE, NEW YORK NY 10019
Michael Hal Weiner officer: Chief Financial Officer C/O NGHC, 59 MAIDEN LANE, 38TH FLOOR, NEW YORK NY 10038
Donald J Klunk officer: Chief Accounting Officer 3585 GRAY FOX DR, CHALFONT PA 18914
Piyush Mehta officer: Senior VP , Human Resources 825 EIGHTH AVENUE, NEW YORK NY 10019
James C. Madden director 825 EIGHTH AVENUE, NEW YORK NY 10019
Cecelia Morken director 26025 MUREAU ROAD, CALABASAS CA 91302
Heather White officer: SVP & General Counsel 1155 AVENUE OF THE AMERICAS, 4TH FLOOR, NEW YORK X1 10036
Stacey Cartwright director 34 ROEDEAN CRESCENT, LONDON X0 SW15 5JU
Brian Mark Stevens director 25 HOOPER HILL RD., NEW BOSTON NH 03070
Ajay Agrawal director 105 ROBERT STREET, TORONTO A6 M5S 2K5
Tamara Franklin director 107 STONE CLIFF ROAD, PRINCETON NJ 08540
Balkrishan Kalra officer: Senior Vice President 5 MARION AVENUE, SHORT HILLS NJ 07078
Carol Lindstrom director 5994 SILVERADO TRAIL, NAPA CA 94558
Darren Saumur officer: Senior Vice President 125 DUPONT STREET, TORONTO A6 M5R 1V4